Scinai Immunotherapeutics Cash Flow Statement (2014-2025) | SCNI

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Sep2014 Dec2014 Sep2015 Mar2016 Jun2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Dec2025
Operating Activities
Net Income (Quarter)
55.89M-11.36M-1.24M-5.81M-5.42M15.75M-1.88M6.91M-0.39M-19.10M3.19M2.60M-7.31M-1.82M1.93M-5.88M10.95M-2.26M
Share-based Compensation (Quarter)
0.48M0.25M
Gains from Sales and Divestitures (Quarter)
278.000.00M0.02M0.03M
Gains from Investment Securities (Quarter)
0.01M0.42M0.01M-0.00M-0.01M0.24M0.11M28.92M-2.57M-0.77M-0.59M-0.22M-0.10M0.00M510.43M
Non-cash Items (Quarter)
3.97M-16.33M3.15M0.09M2.74M0.01M0.01M0.01M0.01M
Change in Working Capital (Quarter)
1.24M-1.61M
Change in Receivables (Quarter)
-0.93M-0.46M1.73M0.22M-2.19M1.22M0.02M-0.12M0.24M-0.02M-0.24M0.14M-0.13M-0.09M0.37M0.15M-0.04M-0.00M-0.03M
Change in Account Payables (Quarter)
0.79M4.14M-6.34M0.07M0.55M0.68M-0.44M0.08M-0.52M0.12M0.15M0.63M-0.66M-0.10M-0.21M0.31M-0.18M-0.23M-0.05M
Change in Accured Expenses (Quarter)
-0.37M0.02M-0.23M-0.24M0.04M-0.05M
Other Working Capital Changes (Quarter)
-0.31M-0.31M-0.31M-0.09M-0.32M-0.31M0.14M-0.06M-0.32M0.00M-0.17M0.01M-0.00M-0.07M-0.12M-0.06M-0.04M
Cash from Operations (Quarter)
-11.84M-10.31M-15.91M-1.16M-7.91M-6.19M-1.86M-1.10M-3.67M-1.90M-0.59M-3.06M-2.88M-2.22M-1.23M-1.46M-1.76M-2.04M-1.08M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
0.16M-0.02M0.00M0.00M0.07M0.11M0.06M
Depreciation & Amortization (CF) (Quarter)
0.60M0.63M0.61M0.18M0.60M0.61M-0.09M0.13M0.14M0.10M0.18M0.14M0.15M0.14M0.08M0.16M0.50M0.50M0.50M
Investing Activities
Capital Expenditures (Quarter)
-1.31M-3.35M-0.10M-0.01M-0.11M-0.00M0.18M0.52M-0.04M-0.08M1.40M-0.01M-0.38M-0.02M1.04M-0.00M-0.01M-0.00M0.02M
Cash from Investing Activities (Quarter)
-1.31M-3.35M0.32M0.00M-0.11M-0.01M-0.11M-0.52M-0.08M-0.08M-0.27M-0.01M-0.38M-0.02M-0.23M-0.00M-0.01M-0.00M
Financing Activities
Other financing activities (Quarter)
3.33M4.60M1.34M0.44M2.58M2.53M0.73M0.48M341.000.33M0.40M0.25M0.20M0.23M0.18M0.19M0.14M0.14M
Cash from Financing Activities (Quarter)
10.03M-0.14M-0.31M12.54M-0.32M-0.99M8.88M-0.47M0.01M2.00M
Additional items
Exchange Rate Effect (Quarter)
-0.64M-0.18M0.55M0.36M-0.36M1.98M-0.29M-0.36M1.57M-0.99M-0.15M-0.22M-0.04M0.01M-0.01M-0.13M0.00M
Change in Cash (Quarter)
-3.75M-13.98M-15.35M11.74M-8.69M-5.21M6.62M-1.99M-9.35M-2.97M5.76M-3.29M-3.29M-1.15M-1.47M-1.92M0.93M
Free Cash Flow (Quarter)
-10.52M-6.96M-15.81M-1.15M-7.80M-6.18M-2.04M-1.63M-3.62M-1.82M-2.00M-3.05M-2.50M-2.20M-2.27M-1.46M-1.75M-2.03M-1.10M
Net Cash Flow (Quarter)
-3.11M-13.80M-15.90M11.39M-8.33M-7.19M6.91M-1.63M-4.22M-1.98M-0.86M-3.06M-3.25M-2.24M-1.46M-1.47M-1.76M-2.03M0.92M